Literature DB >> 21424741

Implantable cardioverter-defibrillator implementation in acute heart failure syndromes: unanswered questions.

Norman C Wang1, Jonathan P Piccini, Mihai Gheorghiade.   

Abstract

Implantable cardioverter-defibrillators have proven efficacy in reducing mortality in patients with reduced left ventricular ejection fraction in both the primary and the secondary prevention settings. All randomized trials demonstrating this benefit have been conducted in outpatients with stable heart failure symptoms. Whether implantable cardioverter-defibrillators confer a benefit when implemented in patients with chronically reduced left ventricular ejection fraction in the acute heart failure setting is unknown. The purpose of this document is to review the existing literature related to this subject.

Entities:  

Mesh：

Year:  2011        PMID： 21424741     DOI： 10.1007/s10741-011-9243-5

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN： 1382-4147            Impact factor:   4.214


  17 in total

1.  Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure.

Authors:  C Lucas; W Johnson; M A Hamilton; G C Fonarow; M A Woo; C M Flavell; J A Creaser; L W Stevenson
Journal:  Am Heart J       Date:  2000-12       Impact factor: 4.749

2.  Implantable cardioverter-defibrillators in patients hospitalized for heart failure with chronically reduced left ventricular ejection fraction.

Authors:  Norman C Wang; Jonathan P Piccini; Marvin A Konstam; Aldo P Maggioni; Brian Traver; Karl Swedberg; James E Udelson; Faiez Zannad; Thomas Cook; Christopher M O'Connor; Alan B Miller; Liliana Grinfeld; Mihai Gheorghiade
Journal:  Am J Ther       Date:  2010 Jul-Aug       Impact factor: 2.688

Review 3.  Selecting patients for discussion of the ICD as primary prevention for sudden death in heart failure.

Authors:  Lynne Warner Stevenson; Akshay S Desai
Journal:  J Card Fail       Date:  2006-08       Impact factor: 5.712

4.  2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation.

Authors:  Sharon Ann Hunt; William T Abraham; Marshall H Chin; Arthur M Feldman; Gary S Francis; Theodore G Ganiats; Mariell Jessup; Marvin A Konstam; Donna M Mancini; Keith Michl; John A Oates; Peter S Rahko; Marc A Silver; Lynne Warner Stevenson; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2009-04-14       Impact factor: 24.094

5.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

6.  Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival.

Authors:  Mina K Chung; Steven J Szymkiewicz; Mingyuan Shao; Edwin Zishiri; Mark J Niebauer; Bruce D Lindsay; Patrick J Tchou
Journal:  J Am Coll Cardiol       Date:  2010-07-13       Impact factor: 24.094

7.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Authors:  Gust H Bardy; Kerry L Lee; Daniel B Mark; Jeanne E Poole; Douglas L Packer; Robin Boineau; Michael Domanski; Charles Troutman; Jill Anderson; George Johnson; Steven E McNulty; Nancy Clapp-Channing; Linda D Davidson-Ray; Elizabeth S Fraulo; Daniel P Fishbein; Richard M Luceri; John H Ip
Journal:  N Engl J Med       Date:  2005-01-20       Impact factor: 91.245

8.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.

Authors: 
Journal:  N Engl J Med       Date:  1997-11-27       Impact factor: 91.245

9.  Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure.

Authors:  Scott D Solomon; Joanna Dobson; Stuart Pocock; Hicham Skali; John J V McMurray; Christopher B Granger; Salim Yusuf; Karl Swedberg; James B Young; Eric L Michelson; Marc A Pfeffer
Journal:  Circulation       Date:  2007-08-27       Impact factor: 29.690

10.  Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction.

Authors:  Norman C Wang; Aldo P Maggioni; Marvin A Konstam; Faiez Zannad; Holly B Krasa; John C Burnett; Liliana Grinfeld; Karl Swedberg; James E Udelson; Thomas Cook; Brian Traver; Christopher Zimmer; Cesare Orlandi; Mihai Gheorghiade
Journal:  JAMA       Date:  2008-06-11       Impact factor: 56.272
View more
  1 in total

Review 1.  Global perspectives in hospitalized heart failure: regional and ethnic variation in patient characteristics, management, and outcomes.

Authors:  Andrew P Ambrosy; Mihai Gheorghiade; Ovidiu Chioncel; Robert J Mentz; Javed Butler
Journal:  Curr Heart Fail Rep       Date:  2014-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.